Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2001, p. 7137-7149, Vol. 21, No. 21
Laboratory of Cellular and Molecular Biology,
National Institute on Aging, National Institutes of Health, Baltimore,
Maryland 21224-6825,1 and The John P. Robarts Research Institute and Departments of Microbiology and
Immunology and of Medicine, The University of Western Ontario, London,
Ontario, Canada N6A 5K82
Received 12 February 2001/Returned for modification 21 March 2001/Accepted 16 July
2001
The tyrosine kinase ZAP-70 has been implicated as a critical
intermediary between T-cell antigen receptor (TCR) stimulation and Erk
activation on the basis of the ability of dominant negative ZAP-70 to
inhibit TCR-stimulated Erk activation, and the reported inability of
anti-CD3 antibodies to activate Erk in ZAP-70-negative Jurkat cells.
However, Erk is activated in T cells receiving a partial agonist
signal, despite failing to activate ZAP-70. This discrepancy led us to
reanalyze the ZAP-70-negative Jurkat T-cell line P116 for its ability
to support Erk activation in response to TCR/CD3 stimulation. Erk was
activated by CD3 cross-linking in P116 cells. However, this response
required a higher concentration of anti-CD3 antibody and was delayed
and transient compared to that in Jurkat T cells. Activation of Raf-1
and MEK-1 was coincident with Erk activation. Remarkably, the time
course of Ras activation was comparable in the two cell lines, despite
proceeding in the absence of LAT tyrosine phosphorylation in the P116
cells. CD3 stimulation of P116 cells also induced tyrosine
phosphorylation of phospholipase C-
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.21.7137-7149.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
ZAP-70-Independent Ca2+ Mobilization
and Erk Activation in Jurkat T Cells in Response to T-Cell Antigen
Receptor Ligation

1 (PLC
1) and increased the
intracellular Ca2+ concentration. Protein kinase C (PKC)
inhibitors blocked CD3-stimulated Erk activation in P116 cells, while
parental Jurkat cells were refractory to PKC inhibition. The
physiologic relevance of these signaling events is further supported by
the finding of PLC
1 tyrosine phosphorylation, Erk activation, and
CD69 upregulation in P116 cells on stimulation with superantigen and
antigen-presenting cells. These results demonstrate the existence of
two pathways leading to TCR-stimulated Erk activation in Jurkat T
cells: a ZAP-70-independent pathway requiring PKC and a
ZAP-70-dependent pathway that is PKC independent.
*
Corresponding author. Mailing address: National
Institute on Aging, 5600 Nathan Shock Dr., MSC-12, Baltimore, MD
21224-6825. Phone: (410) 558-8054. Fax: (410) 558-8107. E-mail:
wanger{at}grc.nia.nih.gov.
Present address: Howard Hughes Medical Institute, Johns
Hopkins School of Medicine, Baltimore, MD 21287.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|